UK Finance Minister Plans Record Tobacco Tax Hike

Feb.24.2023
UK Finance Minister Plans Record Tobacco Tax Hike
UK Chancellor Jeremy Hunt plans the largest tobacco tax increase in history, raising a pack by £1.15.

Recently, according to the Daily Mail, Jeremy Hunt, the Chancellor of the Exchequer in the UK, is planning to implement the biggest tobacco tax increase in British history.


According to reports, Hunter will officially release the budget proposal on March 15th, which includes a tobacco tax increase. A pack of 20 cigarettes will increase by £1.15 (approximately RMB 9.5), representing an increase of over 15%.


Although tobacco taxes usually increase with inflation, some smokers in the UK are hoping the government will temporarily delay the implementation of this decision due to the current high level of inflation.


The tobacco tax has generated nearly £11 billion in revenue for the government, representing 1.2% of all tax revenue for the year. Britain aims to reduce the proportion of smokers in the population to below 5% by the end of the century.


Earlier this year, a public opinion poll revealed that most British people wish to immediately ban the sale of cigarettes. According to a survey conducted by MailOnline, 52% of respondents support a "complete" ban on purchasing cigarettes, while 31% "strongly" support a ban on their sale.


The findings of the survey could provide legislators and health experts with more confidence that public opinion is nearing a crucial moment in favor of a smoking ban. It is reported that the UK previously implemented a ban on smoking in bars and restaurants in 2006 and 2007.


References:


Health Secretary Jeremy Hunt is reportedly considering increasing the tax on tobacco in line with inflation, resulting in a £1.15 rise in the price of a pack of cigarettes, according to sources. The potential move is expected to be announced in next month's budget.


This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

FDA nicotine pouch review delay report knocks tobacco shares lower
FDA nicotine pouch review delay report knocks tobacco shares lower
After Reuters reported before the market open that FDA reviews of nicotine pouch applications could face delays, shares of Philip Morris International, Turning Point Brands and British American Tobacco fell on April 1, underscoring the direct impact of U.S. regulatory signals on major tobacco companies and nicotine pouch expectations.
Apr.02
NACS Urges USTR to Address Illegal E-Cigarette Exports in China Trade Engagements
NACS Urges USTR to Address Illegal E-Cigarette Exports in China Trade Engagements
NACS submitted a comment letter to USTR in a proceeding examining unfair trade practices worldwide. The letter focuses on illicit nicotine products made in China and shipped to the United States in violation of U.S. law. NACS said the U.S. electronic nicotine delivery systems market has become dominated by illicit products, mainly disposable e-cigarettes manufactured in China and sold without the marketing authorization required by the U.S. Food and Drug Administration.
Apr.16 by 2FIRSTS.ai
Reuters Exclusive: FDA’s Fast-Track Review of Nicotine Pouches Slows Over Youth and New-User Concerns
Reuters Exclusive: FDA’s Fast-Track Review of Nicotine Pouches Slows Over Youth and New-User Concerns
Reuters reported on April 1 that several popular nicotine pouch products still have not been cleared for sale in the United States despite a fast-track review pilot run by the U.S. Food and Drug Administration. Three sources said FDA reviewers have taken a cautious approach because of potential risks to youth and other non-tobacco users, including the possibility of driving nicotine addiction among adults who do not already smoke.
Apr.02 by 2FIRSTS.ai
Ispire and Jincheng Pharma Form Joint Venture to Enter Global High-Growth Nicotine Pouch Market
Ispire and Jincheng Pharma Form Joint Venture to Enter Global High-Growth Nicotine Pouch Market
Summary Ispire Technology announced a strategic joint venture with Chinese pharmaceutical company Jincheng Pharma to manufacture and commercialize nicotine pouch products. The partnership combines pharmaceutical-grade production capabilities with Ispire’s global regulatory infrastructure and distribution network as the company expands beyond vaping hardware into oral nicotine products.
Business
May.13
Turning Point Brands Reports Q1 2026 Net Sales of $124.3 Million as Modern Oral Net Sales Rise 133%
Turning Point Brands Reports Q1 2026 Net Sales of $124.3 Million as Modern Oral Net Sales Rise 133%
Turning Point Brands reported first-quarter 2026 results on May 7, covering the period ended March 31, 2026. Total consolidated net sales were $124.3 million, up 16.8% year on year. Gross profit was $68.3 million, up 14.6%, while net income fell 19.0% to $11.7 million. Adjusted EBITDA declined 6.5% to $25.9 million.
May.08 by 2FIRSTS.ai
BAT Appoints Constantinescu as CFO,He Previously Spent 16 Years at the Company
BAT Appoints Constantinescu as CFO,He Previously Spent 16 Years at the Company
BAT has appointed Dragos Constantinescu as chief financial officer. Constantinescu, currently head of Asahi Europe & International, will join the company on September 1 and replace Javed Iqbal, who has served as interim finance chief since August last year
Apr.09 by 2FIRSTS.ai